Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced that its Board of Directors (the “Board”) has ...

Integer Holdings (ITGR) launches a strategic review, weighing a sale/merger or standalone path; plus Q1 FY26 results beat on ...

First quarter results in line with February outlook ~~ Updates 2026 outlook ranges; continues to expect 200bps above-market organic sales ...

Integer Holdings has begun a strategic review to consider a sale, merger, business combination, or continuing its standalone plan, following activist investor engagement and stronger-than-expected Q1 ...

Integer (NYSE:ITGR) reported first-quarter 2026 results that management said were in line with the outlook it provided in ...

The headline numbers for Integer (ITGR) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...

Integer Holdings Corp ITGR reported better-than-expected first-quarter financial results on Thursday. Integer Holdings ...

There is no deadline for the review and no assurance it will result in a transaction. Integer separately lowered its outlook for 2026, citing headwinds with three of its products.

This disposition represented 15.85% of Thomas' direct common stockholdings at the time of the transaction. The transaction was executed via direct ownership; no indirect entities or derivative ...